标题/作者	年份
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 42 (36), 3599-3726	2021
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC Authors/Task Force Members:, TA McDonagh, M Metra, M Adamo, ... European journal of heart failure 24 (1), 4-131	2022
Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association MM Kittleson, MS Maurer, AV Ambardekar, RP Bullock-Palmer, PP Chang, ... Circulation 142 (1), e7-e22	2020
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica SE de Cardiología, Heart Failure Association	2021
Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association K Musunuru, RE Hershberger, SM Day, NJ Klinedinst, AP Landstrom, ... Circulation: Genomic and Precision Medicine 13 (4), e000067	2020
Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis VS Hahn, LR Yanek, J Vaishnav, W Ying, D Vaidya, YZJ Lee, SJ Riley, ... Heart failure 8 (9), 712-724	2020
Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study T Damy, P Garcia‐Pavia, M Hanna, DP Judge, G Merlini, B Gundapaneni, ... European journal of heart failure 23 (2), 277-285	2021
Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging OA Smiseth, DA Morris, N Cardim, M Cikes, V Delgado, E Donal, ... European Heart Journal-Cardiovascular Imaging 23 (2), e34-e61	2022
JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis H Kitaoka, C Izumi, Y Izumiya, T Inomata, M Ueda, T Kubo, J Koyama, ... Circulation Journal 84 (9), 1610-1671	2020
Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis MB Musumeci, F Cappelli, D Russo, G Tini, M Canepa, A Milandri, ... Cardiovascular Imaging 13 (6), 1314-1321	2020
Heart failure association of the ESC, Heart Failure Society of America and Japanese heart failure society position statement on endomyocardial biopsy PM Seferović, H Tsutsui, DM McNamara, AD Ristić, C Basso, B Bozkurt, ... European Journal of Heart Failure 23 (6), 854-871	2021
Canadian Cardiovascular Society/Canadian Heart Failure Society joint position statement on the evaluation and management of patients with cardiac amyloidosis NM Fine, MK Davis, K Anderson, DH Delgado, G Giraldeau, A Kitchlu, ... Canadian Journal of Cardiology 36 (3), 322-334	2020
Transthyretin cardiac amyloidosis AK Mankad, KB Shah Current cardiology reports 19, 1-11	2017
A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy A Huda, A Castaño, A Niyogi, J Schumacher, M Stewart, M Bruno, M Hu, ... Nature communications 12 (1), 2725	2021
ATTR amyloidosis: current and emerging management strategies: JACC: CardioOncology state-of-the-art review JM Griffin, JL Rosenthal, JL Grodin, MS Maurer, M Grogan, RK Cheng Cardio Oncology 3 (4), 488-505	2021
Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy P Garcia‐Pavia, F Bengel, D Brito, T Damy, F Duca, S Dorbala, ... European Journal of Heart Failure 23 (6), 895-905	2021
Impact of delayed diagnosis and misdiagnosis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM): a targeted literature review MH Rozenbaum, S Large, R Bhambri, M Stewart, J Whelan, ... Cardiology and Therapy 10, 141-159	2021
Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement D Bonderman, G Pölzl, K Ablasser, H Agis, S Aschauer, ... Wiener klinische Wochenschrift 132, 742-761	2020
Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation C Cuscaden, SC Ramsay, S Prasad, B Goodwin, J Smith Journal of Nuclear Cardiology 28, 2845-2856	2021
Use of biomarkers to diagnose and manage cardiac amyloidosis V Castiglione, M Franzini, A Aimo, A Carecci, CM Lombardi, C Passino, ... European journal of heart failure 23 (2), 217-230	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。